Stocks
GlaxoSmithKline (GSK) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 15.0 | 1.52 | 1.80 | 12.3 | 6.15 | 10.8 | ||
| Changes by years, y/y, % | +19% | -90% | +18% | +584% | -50% | -13.4% | |||
GlaxoSmithKline. EV/EBITDA
GlaxoSmithKline. EV/EBITDA, changes, %
GlaxoSmithKline (GSK) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 12.6 | 11.2 | 9.86 | 5.48 | 11.7 | 10.8 | |
| Changes by years, y/y, % | +515% | +415% | -31% | -56% | -8% | |||
| Changes by quarters, q/q, % | +2% | -11% | -12% | -44% | +113% | |||
